Trial
NCT04578548
A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Lakefront Biotherapeutics NV
Collaborators
—
Condition
Autosomal Dominant Polycystic Kidney Disease
Intervention
GLPG2737
Why stopped
The study was early terminated due to lack of efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-22